翰宇药业:2026年第一次临时股东会决议公告

Group 1 - The company, Hanyu Pharmaceutical, announced the approval of two key resolutions at its first extraordinary shareholders' meeting of 2026, including a proposal to apply for a credit limit from banks and provide guarantees [2] - The company also approved a resolution to change its auditing firm for the fiscal year 2025 [2]

HYBIO-翰宇药业:2026年第一次临时股东会决议公告 - Reportify